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MicroarrayWhile distinct cell cycle structures have been known to correlate with pluripotent or differentiated cell states [1],
there is no evidence on how the cell cycle machinery directly contributes to human embryonic stem cell (hESC)
pluripotency.Weestablished a determinant role of cell cyclemachineries on the pluripotent state bydemonstrat-
ing that the speciﬁc perturbation of the S and G2 phases can prevent pluripotent state dissolution (PSD) [2]. Ac-
tive mechanisms in these phases, such as the DNA damage checkpoint and Cyclin B1, promote the pluripotent
state [2]. To understand the mechanisms behind the effect on PSD by these pathways in hESCs, we performed
comprehensive gene expression analysis by time-course microarray experiments. From these datasets, we ob-
served expression changes in genes involved in the TGFβ signaling pathway, which has a well-established role
in hESC maintenance [3–5]. The microarray data have been deposited in NCBI's Gene Expression Omnibus
(GEO) and can be accessed through GEO Series accession numbers GSE62062 and GSE63215.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Speciﬁcationsrganism/cell
line/tissueHomo sapiens/H1/human embryonic stem cellsx Male
quencer or
array typeIllumina HumanHT-12 V4.0 expression beadchip (microarray)ata format Raw and analyzed
xperimental
factorshESCs were incubated in either hESC medium or hESC medium
without bFGF and TGFβ for 0, 48 and 96 h. hESCs were treated
with either DMSO, Aphidicolin or Aphidicolin + AZD7762 or
with either control or CCNB1 overexpression lentiviral
constructs.xperimental
featuresAnalysis of the effect of S phase arrest and replication check-
point activation or Cyclin B1 overexpression on differentiating
hESCs at the gene expression level.onsent N/A
ample source
locationSingapore1. Direct link to deposited data
Deposited data can be found at http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE62062 and http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE63215.. This is an open access article under2. Experimental design, materials and methods
2.1. Cell culture
The hESC line H1 (passage 30) was used for this study. They were
cultured feeder-free on Matrigel (BD). hESCs were maintained by
daily replenishment with mTeSR1 medium (STEMCELL Technologies).
Routine subculture as clumps was executed when hESCs reach
conﬂuency every 4–5 days using 1 U/mL Dispase in DMEM/F12
(STEMCELL Technologies).
Prior to all treatments, hESCs were instead passaged as single cells
using TrypLE™ Express (Life Technologies). 2 h after passage, treat-
ments were applied. 24 h after treatment, medium was replaced to
mTeSR1 without select growth factors (STEMCELL Technologies) to in-
duce PSD (Fig. 1).
2.2. Experimental groups and conditions
To understand the effects of DNA replication perturbation and acti-
vation of the DNA damage checkpoint in hESCs undergoing PSD, we
supplemented hESCs either with DMSO, with the DNA polymerase in-
hibitor Aphidicolin (75 ng/mL, Sigma), or with Aphidicolin plus the
checkpoint kinase inhibitor AZD7762 (100 nM, SelleckChem).
To understand effects of Cyclin B1 overexpression in hESCs undergo-
ing PSD, we infected hESCs either with the unmodiﬁed pLVTH vector or
with the open reading frame of CCNB1 inserted using the PmeI andNdeIthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Outline of time-course experiment prior to microarray analysis.
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2 μL of concentrated viruses to the culture medium with 4 μg/mL
polybrene (Sigma).
Triplicate samples were prepared for each condition, and RNA was
collected at 0, 48 and 96 h after induction of PSD (Fig. 1).
2.3. RNA extraction
Cells were lysed with TRIzol® (Invitrogen) and RNA was extracted
using standard chloroform-isopropanol procedure. RNAs were puriﬁed
by DNAse I treatment (NEB) followed by column-puriﬁcation using
PureLink RNA Mini Kit (Ambion).
2.4. Microarray hybridization and analysis
250 ng of puriﬁed RNA was used to synthesize cDNA, followed by
in vitro transcription for 14 h and cRNA puriﬁcation, all using Illumina
TotalPrep RNA Ampliﬁcation Kit (Ambion). 750 ng of the puriﬁed
biotin-labeled cRNA was used for hybridization for 18 h onto the
HumanHT-12 v4 Expression BeadChips.
After hybridization, the raw images were obtained using Illumina
BeadArray Reader. Rank invariant normalization and analysis were
performed using GenomeStudio Software. Only probes with detection
p-value b 0.05 in all three replicates of at least one sample were consid-
ered for analysis. Differentially expressed genes were obtained using
the Signiﬁcance Analysis of Microarrays software (http://statweb.
stanford.edu/~tibs/SAM/) and gene ontology analysis was done using
DAVID (https://david.ncifcrf.gov/).
3. Discussion
Dramatic biochemical and physical changes occur during progres-
sion through the cell cycle. Cells have evolved to utilize the differences
between cell cycle phases to prime or regulate other processes that
are not directly related to proliferation [6–9]. We have demonstrated
that interfering with DNA replication during the S phase or delaying
progression in the G2 phase dominantly delays PSD [2]. Particularly,
we ﬁnd that the ATM/ATR-CHEK2-mediated DNA damage checkpoint
and Cyclin B1 actively promote the pluripotent state in the S and G2phases, respectively. To obtain a mechanistic connection between
these pathways and pluripotency, we performed a time-course micro-
array analysis as described here. The datasets provided important infor-
mation on the response of hESCs to DNA damage checkpoint activation,
such as gene expression changes that lead to enhanced TGFβ signaling,
which subsequently promotes the pluripotent state [3–5]. Similar
changeswere observed for Cyclin B1 overexpression, together with cor-
responding changes in mesoderm- and neuroectoderm-associated
genes. In summary, our results demonstrate that the S and G2 phases
possess an intrinsic propensity towards the pluripotent state, through
active pathways that heighten TGFβ signaling. Knowledge on the regu-
latory network of PSD can be utilized to improve current differentiation
protocols, andwe hope that this resourcewill serve as a valuable tool for
understanding PSD in hESCs and how this process is hardwired to the
cell cycle.
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